[ROLE OF METABOLIC DISORDERS IN THE DETERMINISM OF CERTAIN COMPLICATIONS OF ANTITUBERCULAR CHEMOTHERAPY].
D000995:Antitubercular Agents; D001361:Avitaminosis; D003880:Dermatology; D005000:Ethionamide; D005762:Gastroenterology; D006168:Guinea Pigs; D006801:Humans; D007538:Isoniazid / Q000633:toxicity*; D001523:Mental Disorders; D009092:Mucous Membrane; D009443:Neuritis; D009525:Niacin; D009536:Niacinamide; D012106:Research; D014116:Toxicology; D026681:Vitamin B 6 Deficiency
D000995:Antitubercular Agents; D009536:Niacinamide; D009525:Niacin; D005000:Ethionamide; D007538:Isoniazid
AVITAMINOSIS; DERMATOLOGY; ETHIONIAMIDE; EXPERIMENTAL LAB STUDY; GASTROENTEROLOGY; GUINEA PIGS; ISONIAZID TOXICOLOGY; MENTAL DISORDERS; MUCOUS MEMBRANE; NEURITIS; NICOTINAMIDE; PYRIDOXINE DEFICIENCY; TOXICOLOGIC REPORT
R OLE DES TROUBLES M'ETABOLIQUES DANS LE D'ETERMINISME DE CERTAINS ACCIDENTS DE LA CHIMIOTH'ERAPIE ANTI-TUBERCULEUSE.